1
Home
Companies

Cormedix

#5983

Rank

$788.12M

Marketcap

US United States

Country

Cormedix
Leadership team

Dr. Matthew T. David M.D. (Exec. VP & CFO)

Dr. Phoebe Mounts Esq., Ph.D. (EVP, Gen. Counsel, Head of Regulatory, Compliance, Legal & Technical Operations and Sec.)

Ms. Elizabeth Masson-Hurlburt B.A. (Exec. VP & Head of Clinical Operations)

Products/ Services
Biotechnology, Health Care, Health Diagnostics
Headquarters
Bridgewater, New Jersey, United States
Established
2006
Company Registration
SEC CIK number: 0001410098
Traded as
CRMD
Social Media
URL
https://www.cormedix.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
History

Since its inception in 2006, CorMedix has focused its efforts on the development of Neutrolin®, its lead product, a novel ionic liquid therapeutic dressing designed to prevent, reduce, and and treat infection from central lines and other vascular access devices.

Mission
Our mission is to provide novel and innovative treatments for cardiac and renal dysfunction, and to improve the quality of life for our patients and North America.
Vision
We see a future in which new medicines and treatments for cardiac and renal dysfunction allow patients to live healthier and happier lives.
Key Team

Mr. Joseph Todisco MBA (CEO & Director)

Donna Ucci (Sr. VP & Head of Global Quality)

Recognition and Awards
CorMedix is the recipient of numerous national and international awards including the Walter M. Clore Prize, the Tibbetts Award, and the Jonas Salk Award.
References

https://in.investing.com/equities/cormedix-inc

https://finance.yahoo.com/quote/CRMD/profile?p=CRMD

https://www.crunchbase.com/organization/cormedix

https://companiesmarketcap.com/

https://www.cormedix.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Cormedix
Leadership team

Dr. Matthew T. David M.D. (Exec. VP & CFO)

Dr. Phoebe Mounts Esq., Ph.D. (EVP, Gen. Counsel, Head of Regulatory, Compliance, Legal & Technical Operations and Sec.)

Ms. Elizabeth Masson-Hurlburt B.A. (Exec. VP & Head of Clinical Operations)

Products/ Services
Biotechnology, Health Care, Health Diagnostics
Headquarters
Bridgewater, New Jersey, United States
Established
2006
Company Registration
SEC CIK number: 0001410098
Traded as
CRMD
Social Media
URL
https://www.cormedix.com